Page last updated: 2024-09-04

moxifloxacin and 1-(3-chlorophenyl)piperazine

moxifloxacin has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(1-(3-chlorophenyl)piperazine)
Trials
(1-(3-chlorophenyl)piperazine)
Recent Studies (post-2010) (1-(3-chlorophenyl)piperazine)
3,1575521,69083314287

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)1-(3-chlorophenyl)piperazine (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1

Other Studies

1 other study(ies) available for moxifloxacin and 1-(3-chlorophenyl)piperazine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008